We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
+4.37%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$3.26B
AUM Growth
-$60.9M
Cap. Flow
-$92.3M
Cap. Flow %
-2.83%
Top 10 Hldgs %
25.7%
Holding
357
New
19
Increased
56
Reduced
184
Closed
64

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$40.7M
2
RDDT icon
Reddit
RDDT
+$31.5M
3
MTSI icon
MACOM Technology Solutions
MTSI
+$13.3M
4
FCFS icon
FirstCash
FCFS
+$10.8M
5
DKNG icon
DraftKings
DKNG
+$10.5M

Top Sells

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$37.4M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$23.2M
3
AMZN icon
Amazon
AMZN
+$12.7M
4
CIEN icon
Ciena
CIEN
+$12.1M
5
CNM icon
Core & Main
CNM
+$11.8M

Sector Composition

Rank Sector Weight
1 Technology 28.22%
2 Healthcare 15.69%
3 Financials 15.15%
4 Consumer Discretionary 13.95%
5 Industrials 10.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LTH icon
126
Life Time Group Holdings
LTH
$9.79B
$7.35M 0.23%
276,498
-3,751
-1% -$97.6K
ADPT icon
127
Adaptive Biotechnologies
ADPT
$4.04B
$7.35M 0.23%
452,502
-70,300
-13% -$1.15M
TMDX icon
128
Transmedics
TMDX
$3.1B
$7.32M 0.22%
60,157
-8,249
-12% -$1.04M
VCEL icon
129
Vericel Corp
VCEL
$2.27B
$7.32M 0.22%
203,197
-2,731
-1% -$100K
VVV icon
130
Valvoline
VVV
$4.21B
$7.18M 0.22%
246,950
-2,991
-1% -$96K
ALGM icon
131
Allegro MicroSystems
ALGM
$7.93B
$7.15M 0.22%
270,888
-3,589
-1% -$98.8K
ALKS icon
132
Alkermes
ALKS
$8.26B
$7.12M 0.22%
254,333
-3,462
-1% -$104K
WGS icon
133
GeneDx Holdings
WGS
$2.44B
$7.03M 0.22%
54,038
-20,209
-27% -$2.77M
ONT
134
Onterris Inc
ONT
$576M
$6.96M 0.21%
280,171
-3,728
-1% -$98.5K
OCUL icon
135
Ocular Therapeutix
OCUL
$2.14B
$6.93M 0.21%
571,103
-46,416
-8% -$564K
CYTK icon
136
Cytokinetics
CYTK
$10.6B
$6.87M 0.21%
108,062
-46,387
-30% -$2.89M
SRRK icon
137
Scholar Rock
SRRK
$6.34B
$6.73M 0.21%
152,854
-2,047
-1% -$76.8K
BIRK icon
138
Birkenstock
BIRK
$6.89B
$6.73M 0.21%
164,583
-2,246
-1% -$95.1K
GRDN
139
Guardian Pharmacy Services
GRDN
$2.5B
$6.65M 0.2%
221,056
-10,955
-5% -$310K
VIRT icon
140
Virtu Financial
VIRT
$4.86B
$6.63M 0.2%
198,997
-6,746
-3% -$231K
SHLS icon
141
Shoals Technologies Group
SHLS
$1.47B
$6.62M 0.2%
+778,874
New +$7M
BRKR icon
142
Bruker
BRKR
$8.69B
$6.54M 0.2%
138,804
+138,304
+27,661% +$5.84M
PHIN icon
143
Phinia Inc
PHIN
$2.74B
$6.53M 0.2%
104,097
-44,933
-30% -$2.48M
RBA icon
144
RB Global
RBA
$16.6B
$6.47M 0.2%
62,937
-3,267
-5% -$332K
FIBK icon
145
First Interstate BancSystem
FIBK
$3.62B
$6.39M 0.2%
184,666
-9,133
-5% -$299K
GATX icon
146
GATX Corp
GATX
$6.27B
$6.38M 0.2%
37,600
-1,865
-5% -$307K
TRVI icon
147
Trevi Therapeutics
TRVI
$2.54B
$6.36M 0.19%
507,685
-112,779
-18% -$1.3M
R icon
148
Ryder
R
$9.92B
$6.35M 0.19%
33,173
-16,729
-34% -$3.01M
COLB icon
149
Columbia Banking Systems
COLB
$8.97B
$6.35M 0.19%
227,077
-11,200
-5% -$303K
FBK icon
150
FB Financial Corp
FBK
$3.07B
$6.31M 0.19%
113,088
-5,673
-5% -$317K
4 5
6
7 8

Similar funds

CAM
Contour Asset Management New York $3.08B AUM 21.94% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
SAG
Susquehanna Advisors Group Bala Cynwyd, Pennsylvania $3.05B AUM 41.49% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Peregrine Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Peregrine Capital Management held 357 positions worth $3.26B, down 1.8% from $3.32B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Peregrine Capital Management's Q4 2025 filing shows 19 new, 56 increased, 184 reduced and 64 closed positions. Its largest new stake was Eli Lilly: 42,567 shares worth $45.7M. The largest sale was Exact Sciences, an estimated $37.4M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.

  • Peregrine Capital Management's largest Q4 2025 buy was Eli Lilly: 42,567 shares worth $45.7M.
  • Peregrine Capital Management added most to DraftKings in Q4 2025, an estimated $10.5M increase.
  • Peregrine Capital Management's biggest Q4 2025 reduction was Exact Sciences, cutting an estimated $37.4M.
  • Peregrine Capital Management fully exited Core & Main in Q4 2025, selling an estimated $11.8M.
  • Peregrine Capital Management's ten largest holdings make up 26% of its $3.26B portfolio in Q4 2025.
  • Peregrine Capital Management opened 19 new positions and closed 64 in Q4 2025.
  • Peregrine Capital Management's portfolio value fell 1.8% quarter-over-quarter to $3.26B.

Based on Peregrine Capital Management's 13F filing for Q4 2025, filed 28 Jan 2026.